Fmoc-L-Ile-OH CAS:71989-23-6

Fmoc-L-Ile-OH inoita basa rakakosha mukugadzirwa kwepeptide nekushanda sechinhu chakakosha mukudzivirira boka re carboxyl re isoleucine panguva yekureba kwepeptide. Dziviriro iyi inoita kuti pave nekuumbwa kwe amide bond, zvichiita kuti pave nekuungana kwakarongwa kwe complex peptide sequences nekuchena kwakanyanya uye goho. Vatsvaguri vanoshandisa iyi compound kugadzira ma peptide structures akagadzirirwa ane hunhu hwakakosha, hunokosha pakudzidza hukama hwe structure-activity mukugadzirwa kwemishonga nekugadzirwa kwayo. Uyezve, Fmoc-L-Ile-OH inobatsira mukugadzirwa kwe peptide-based therapeutics, molecular probes, uye biomaterials. Nekubatanidza iyi compound mu peptide constructs, masayendisiti anogona kugadzirisa hunhu hwemamorekuru anokonzerwa kuti awane mabasa e biological akananga, anosanganisira receptor binding, enzyme inhibition, uye cellular targeting. Hunhu hwemakemikari chaiwo e compound iyi hunoitawo kuti ive yakakosha mukugadzira peptide conjugates yekupa mishonga yakananga uye sezvishandiso zvekuferefeta kudyidzana kwemapuroteni nemapuroteni. Mashandisirwo ayo akasiyana-siyana anosvika pakufambira mberi mu medical chemistry, structural biology, uye pharmacology, zvichiratidza kukosha kwayo mukutsvagisa kwesainzi uye mhinduro dzekurapa itsva. Muchidimbu, Fmoc-L-Ile-OH chinhu chakakosha mumakemikari epeptide, chinoshanda sechinhu chikuru mukugadzirwa kwema peptide akasiyana-siyana ane mabasa akagadzirirwa. Mashandisirwo ayo anosanganisira kugadzirwa kwemishonga, kutsvagurudza kwemakemikari, uye biotechnology, zvichiratidza kukosha kwayo mukusimudzira ruzivo rwesainzi uye kubatsira mukuvandudzwa kwenzira itsva dzekurapa.